Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 157, Issue 2, Pages 225-234Publisher
WILEY
DOI: 10.1111/j.1365-2249.2009.03956.x
Keywords
cytokine; innate immunity; TLR; VIP
Categories
Ask authors/readers for more resources
Since the late 1970s a number of laboratories have studied the role of vasoactive intestinal peptide (VIP) in inflammation and immunity. These studies have highlighted the dramatic effect of VIP on immune cell activation and function, and studies using animal models of disease have indicated that VIP has significant therapeutic and prophylactic potential. This review will focus on the effects of VIP on innate immune cell function and discuss the therapeutic potential for VIP in inflammatory diseases of humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
